Data made the difference: A primary care physician says lab data helped save a life

Learn more about how a doctor used Labcorp digital solutions to discover new patient’s esophageal cancer.

Robert Schmidt, MD, PhD, MBA

Robert Schmidt, MD, PhD, MBA is the medical director for health systems and head of population analytics at Labcorp. His work focuses on the use of laboratory data to identify and close gaps in care. He is also responsible for Labcorp’s laboratory stewardship initiative. Prior to joining Labcorp, Dr.

Actionable insights: Utilizing lab data for health equity initiatives

 

Many healthcare organizations have a desire to proactively identify and address healthcare inequities among their underserved and vulnerable patient populations. Using population-level lab data, health systems are positioned to improve patient outcomes and better meet value-based care goals.

Watch this presentation with Linda Fraunhofer, director of population initiatives at Labcorp, to learn:

Ke Chen, PhD

Ke Chen earned his PhD from Donghua University in 2018 with his research focusing on nucleic acid testing. After graduation, he joined Labcorp Central Laboratory Services as a genomics scientist.

In his current role, Ke is responsible for method validation and test assay troubleshooting. He has extensive knowledge in the field of molecular detection methods, especially in qPCR and next-generation sequencing.

Jane Craig, PhD

Dr. Jane Craig is a Scientist in Flow Cytometry Validation Services at Labcorp Central Labs. She works with biotech and pharmaceutical clients to build and validate custom flow cytometry panels to be used during clinical trials. Panels span a variety of topics and therapeutic areas, such as CART cell persistence, receptor occupancy, immune-phenotyping, and functional testing.

Jane has worked in flow cytometry for 7 years and has experience with the BD LSRFortessa, BD FACSCanto II, BD FACSLyric, and Bio-Rad ZE5 and has validated panels with up to 17 colors.

Nadia Ayala-Lopez, PhD, MLS (ASCP), DABCC, NRCC

Dr. Ayala-Lopez is director of clinical chemistry in medical affairs at Labcorp Drug Development where she provides medical, scientific, and regulatory support for the Central Laboratory Services in the areas of hematology, clinical chemistry, special chemistry, analytical chemistry, and toxicology. She also serves as the medical laboratory director for Labcorp Bioanalytical Services in Indianapolis, Indiana.

Labcorp awarded Forrester Research 2023 Customer Obsession Leadership Award

BURLINGTON, N.C. , June 14, 2023 /PRNewswire/ --  Labcorp  (NYSE: LH), a leading global life sciences company, is pleased to share that its executive vice president and chief marketing officer, Amy Summy , has been awarded the inaugural Forrester Customer Obsession Leadership Award, recognizing

Understanding the Bhas 42 cell transformation assay: A first step in detecting carcinogenesis

Responding to a need to provide testing solutions that may help reduce timelines, costs and complexities for our drug development partners, Labcorp is pleased to now offer the Bhas 42 cell transformation assay (CTA) in support of preclinical toxicology studies. 

Labcorp announces pricing of Fortrea $570 million Notes Offering in connection with anticipated Fortrea spinoff

BURLINGTON, N.C. , June 12, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Fortrea Holdings Inc. , a wholly owned subsidiary of Labcorp ("Fortrea"), has priced an offering of $570 million of senior secured notes due 2030 (the "Notes"), in